| Business model |
|
|
Artimplant’s business model is based on the exploitation and development of the patented biomaterial platform Artelon®, from which implants in different clinical areas are being developed.
Product development, production, clinical studies, central marketing documentation and sales training are handled by Artimplant. Sales and local marketing take place primarily in the USA and Europe through the following channels:
|